Cincinnati Bell Announces Completion of Reverse Stock Split
Oct 05, 2016 11:50 am UTC| Business
CINCINNATI, Oct. 05, 2016 -- Cincinnati Bell Inc. (NYSE:CBB) today announced the completion of its previously announced 1-for-5 reverse stock split of its outstanding and treasury common shares effective as of 11:59...
Biofungicide CR-10 Keeps Winning Battles Against Coffee Rust In Guatemala And Costa Rica
Oct 05, 2016 11:30 am UTC| Business
Phoenix, Oct. 05, 2016 -- / BioNovelus, Inc. (PINKSHEETS: ONOV) is pleased to share the latest very successful test results of its bio-fungicide CR-10, in the fight against coffee leaf rust (Hemileia vastatrix or “roya”...
OMA reports a 15.5% increase in September 2016 passenger traffic
Oct 05, 2016 11:30 am UTC| Business
MONTERREY, Mexico, Oct. 05, 2016 -- Mexican airport operator Grupo Aeroportuario del Centro Norte, S.A.B. de C.V., known as OMA (NASDAQ:OMAB) (BMV:OMA), reports that terminal passenger traffic at its 13 airports...
WealthIntel, Inc Initiates Private Placement Offering of Series A Convertible Preferred Shares
Oct 05, 2016 11:07 am UTC| Business
LAS VEGAS, Oct. 05, 2016 -- WealthIntel is proceeding with its non-brokered private placement offering of up to 4,000,000 Series A Convertible Preferred shares to accredited Investors both domestic and international...
Collegium Submits Supplemental New Drug Submission to FDA for Xtampza® ER
Oct 05, 2016 11:06 am UTC| Business
CANTON, Mass., Oct. 05, 2016 -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) announced today that it has submitted a Supplemental New Drug Application (sNDA) to the U.S. Food Drug Administration (FDA) to enhance the...
Hunt Mining Announces Key Personnel for Martha Project Production
Oct 05, 2016 11:01 am UTC| Business
LIBERTY LAKE, Wash., Oct. 05, 2016 -- Hunt Mining Corp. ("Hunt" or the "Company") (TSXV:HMX) is pleased to announce two additions to the Company’s management team; both of whom formerly worked with Coeur Argentina at...
Oct 05, 2016 11:01 am UTC| Business
The Phase II clinical study is intended to evaluate the efficacy and safety of YELIVA™ (ABC294640) in patients with advanced hepatocellular carcinoma (HCC), the most common primary malignant cancer of the liver with a...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Economist Chris Richardson on an ‘ugly’ inflation result and the coming budget
The Mattei Plan: why Giorgia Meloni is looking to Africa
Labour can afford to be far more ambitious with its economic policies – voters are on board
Sudan: civil war stretches into a second year with no end in sight